Medicine and Dentistry
ST Segment Elevation Myocardial Infarction
100%
Percutaneous Coronary Intervention
74%
Primary Percutaneous Coronary Intervention
68%
Percutaneous Aortic Valve Replacement
63%
Acute Heart Infarction
35%
Infarction
28%
Out of Hospital Cardiac Arrest
28%
Myocardial Infarction
25%
Cardiogenic Shock
22%
Umirolimus
21%
Aortic Stenosis
21%
Revascularization
21%
Coronary Angiography
20%
Rapamycin
20%
Aortic Valve
16%
Target Lesion
16%
Optical Coherence Tomography
14%
Heart Arrest
14%
ST Elevation
14%
Assisted Circulation
13%
Electrocardiogram
13%
Hemodynamic
13%
Coronary Artery Disease
12%
Hazard Ratio
12%
Drug-Eluting Stent
12%
Randomized Clinical Trials
12%
Randomized Controlled Trial
11%
Extracorporeal
11%
Fractional Flow Reserve
11%
Acute Coronary Syndrome
10%
Ischemia
10%
Stent Thrombosis
10%
Odds Ratio
10%
Elution
9%
Target Lesion Revascularization
9%
Angiography
9%
All Cause Mortality
9%
Congestive Heart Failure
9%
Troponin T
9%
Heart Muscle Ischemia
9%
Heart Death
8%
Dyspnea
8%
Noninferiority Trial
8%
Ejection Fraction
7%
Stenting
7%
Computed Tomography Angiography
7%
Stenosis
7%
Ischemic Heart Disease
7%
Observational Study
7%
Apoplexy
6%
Keyphrases
ST-elevation Myocardial Infarction (STEMI)
76%
Percutaneous Coronary Intervention
48%
Primary Percutaneous Coronary Intervention
35%
Confidence Interval
25%
Transcatheter Aortic Valve Implantation
25%
Clinical Outcomes
23%
Out-of-hospital Cardiac Arrest
21%
Cardiogenic Shock
18%
Revascularization
17%
Biodegradable Polymers
17%
Randomized Clinical Trial
16%
Sirolimus
16%
Stent
15%
Myocardial Infarction
15%
Target Lesion Failure
15%
Flow Pump
14%
Acute Myocardial Infarction
14%
Biolimus
13%
Denmark
13%
Transcatheter Aortic Valve Replacement
12%
Orsiro Stent
11%
Shock
11%
Randomized Trial
11%
All-cause Mortality
10%
Infarct
10%
Dual Therapy
9%
Drug-eluting Stent
9%
Acute Coronary Syndrome
9%
Biolimus-eluting Stent
9%
Coronary Angiography
9%
Target Lesion Revascularization
9%
Optical Coherence Tomography
9%
Ultra-thin Strut
8%
Cardiac Death
8%
Randomized Comparison
8%
Anti-CD34 Antibody
8%
Mechanical Circulatory Support
8%
Stent Thrombosis
8%
Hazard Ratio
8%
Transcatheter Heart Valve
7%
Stent Implantation
7%
Odds Ratio
6%
Type 1 Diabetes Mellitus (T1DM)
6%
Sirolimus-eluting Stent
6%
Rate Ratio
6%
Distal Protection
6%
Extracorporeal Cardiopulmonary Resuscitation
6%
Return of Spontaneous Circulation
6%
System Delay
6%
Ischemia
6%